Project Grant HT9425261E031
Award Date 6/1/26
Completion Date 5/31/29
Dollars Obligated $398K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $968,875 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. The award funds research to identify and assess immunotherapy targets in neurofibromatosis type 2 (NF2)-associated schwannomatosis, a rare genetic disorder characterized by the development of multiple...
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $2.1M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period June 1, 2026 through May 31, 2029. The award supports research focused on targeting age-driven metastatic vulnerabilities in triple-negative breast cancer, a critical health priority within the DHA's portfolio of biomedical research initiatives. As a National Cancer...
- Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $1,124,896 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, for a four-year performance period concluding July 14, 2029. The award funds research characterizing the role of aberrant FGD1 (FYVE, RhoGEF and PH Domains-containing Protein 1) splicing in brain and bone metastasis in clear cell renal cell...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $459,360 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on genetic risk factors associated with prostate cancer in self-identified Black veterans. The three-year award, which commenced July 1, 2025 and concludes June 30, 2028, supports hypothesis-driven biomedical research aimed at advancing...
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $798,673 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with an ultimate completion date of June 14, 2029. The award funds research to characterize the role of aberrant FGD1 splicing in brain and bone metastasis in clear cell renal cell carcinoma. This research aims to advance understanding of metastatic mechanisms...
- Summary of Federal Cooperative Agreement Award H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $18.7 million Cooperative Agreement from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 1, 2025, with a completion date of August 31, 2029. The award funds a four-year research initiative focused on developing and evaluating combinatorial therapies utilizing dendritic cell therapies to...
- Federal Grant Award Summary Fred Hutchinson Cancer Center received a $2.112 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the four-year period from July 1, 2025 through June 30, 2029. The grant supports research titled "Prevention of Liver Metastasis by Defining Regulators of Tumor Dormancy, How They Are Disrupted, and How to Reverse It," conducted at the center's Seattle, Washington facility....
- The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying novel...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- This $1,619,065.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER" project. The grant, awarded on April 15, 2025, provides funding to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a National Cancer Institute-designated comprehensive cancer center in Tampa, Florida, to develop an...